Harada H - Search Results

1

Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.

Miyawaki T, Naito T, Doshita K, Kodama H, Mori M, Nishioka N, Iida Y, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ko R, Wakuda K, Ono A, Kenmotsu H, Murakami H, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: harada h. Thorac Cancer. 2022 Jul;13(14):2064-2074. doi: 10.1111/1759-7714.14529. Epub 2022 Jun 13. Thorac Cancer. 2022. PMID: 35698259 Free PMC article. Review.

2

Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column: a review of 544 patients at Shizuoka Cancer Center Hospital.

Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, Takagi T, Katagiri H, Takahashi M, Nishimura T. Mizumoto M, et al. Among authors: harada h. Cancer. 2008 Nov 15;113(10):2816-22. doi: 10.1002/cncr.23888. Cancer. 2008. PMID: 18846565 Free article.

3

Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer.

Harada H, Yamamoto N, Takahashi T, Endo M, Murakami H, Tsuya A, Nakamura Y, Ono A, Igawa S, Shukuya T, Tamiya A, Nishimura T. Harada H, et al. Int J Clin Oncol. 2009 Dec;14(6):507-12. doi: 10.1007/s10147-009-0907-2. Epub 2009 Dec 5. Int J Clin Oncol. 2009. PMID: 19967486

4

Metastatic skull tumors: MRI features and a new conventional classification.

Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Yuen S, Asakura K, Endo M. Mitsuya K, et al. Among authors: harada h. J Neurooncol. 2011 Aug;104(1):239-45. doi: 10.1007/s11060-010-0465-5. Epub 2010 Nov 26. J Neurooncol. 2011. PMID: 21110218 Free PMC article.

5

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure.

Shukuya T, Takahashi T, Naito T, Kaira R, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Murakami H, Harada H, Mitsuya K, Endo M, Nakasu Y, Takahashi K, Yamamoto N. Shukuya T, et al. Among authors: harada h. Lung Cancer. 2011 Dec;74(3):457-61. doi: 10.1016/j.lungcan.2011.04.007. Epub 2011 May 14. Lung Cancer. 2011. PMID: 21571388

6

Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).

Harada H, Seto T, Igawa S, Tsuya A, Wada M, Kaira K, Naito T, Hayakawa K, Nishimura T, Masuda N, Yamamoto N. Harada H, et al. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1777-82. doi: 10.1016/j.ijrobp.2011.03.037. Epub 2011 May 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 21621337 Clinical Trial.

7

Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer.

Inomata M, Shukuya T, Takahashi T, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Harada H, Endo M, Yamamoto N. Inomata M, et al. Among authors: harada h. Anticancer Res. 2011 Dec;31(12):4519-23. Anticancer Res. 2011. PMID: 22199325

8

Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.

Shukuya T, Takahashi T, Harada H, Akamatsu H, Sakaguchi C, Imai H, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Endo M, Takahashi K, Yamamoto N. Shukuya T, et al. Among authors: harada h. Anticancer Res. 2012 Feb;32(2):675-80. Anticancer Res. 2012. PMID: 22287762

9

[Multidisciplinary treatment of leptomeningeal metastasis in patients with lung adenocarcinoma: the triple modality combination of EGFR-TKI, VP shunt and irradiation].

Mitsuya K, Nakasu Y, Mizokami Y, Takahashi T, Nakamura Y, Ono A, Toda Y, Yamamoto N, Harada H, Nishimura T. Mitsuya K, et al. Among authors: harada h. No Shinkei Geka. 2012 Jun;40(6):503-9. No Shinkei Geka. 2012. PMID: 22647509 Japanese.

10

The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapy.

Akamatsu H, Kaira K, Murakami H, Serizawa M, Koh Y, Ono A, Shukuya T, Tsuya A, Nakamura Y, Kenmotsu H, Naito T, Takahashi T, Endo M, Harada H, Nakajima T, Yamamoto N. Akamatsu H, et al. Among authors: harada h. Am J Clin Oncol. 2014 Apr;37(2):144-7. doi: 10.1097/COC.0b013e31826e04f9. Am J Clin Oncol. 2014. PMID: 23211219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,616 results

Search Page